| 查看: 2048 | 回复: 9 | ||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | ||
[求助]
Nexplanon的专利帮忙找找~~~~~~~~~~
|
||
|
Merck公司近日表示在美国上市68mg的Nexplanon (etonogestrel、依托孕烯) 皮下植入棒式避孕药。 这个避孕药的专利找不到，请高手们帮帮忙！！ |
回复此楼» 猜你喜欢
酰胺脱乙酰基
已经有9人回复
-
有时候真觉得大城市人没有县城人甚至个体户幸福
已经有3人回复
-
CSC & MSCA 博洛尼亚大学能源材料课题组博士/博士后招生｜MSCA经费充足、排名优
已经有5人回复
-
有70后还继续奋斗在职场上的吗？
已经有6人回复
-
博士延得我，科研能力直往上蹿
已经有7人回复
-
退学或坚持读
已经有27人回复
-
面上基金申报没有其他的参与者成吗
已经有5人回复
-
遇见不省心的家人很难过
已经有22人回复
» 本主题相关价值贴推荐，对您同样有帮助:
- 大家进来帮帮忙，参考下该投什么杂志
已经有4人回复
- 帮忙翻译下面一段法语文献（化学）
已经有4人回复
- 帮忙翻译一个日文专利
已经有8人回复
- 请帮忙查看文章是否已被SCI收录，谢谢！
已经有3人回复
- 想合成一种高分子材料用于环境污染治理，虫友们帮忙出出点子吧
已经有5人回复
- 请大家帮忙分析一下这两个研究方向哪个更适合我呢？
已经有4人回复
- 关于流体机械的书籍，大虾帮帮忙！
已经有3人回复
- 急，请帮忙看看这个句子，谢谢
已经有3人回复
- 帮忙翻译一句专利，在线等
已经有2人回复
- 以下几个会议的论文 istp 能检索到的么？ 有谁能帮忙查下么？谢谢啦
已经有3人回复
- 重金帮忙翻译一段日语专利，急！
已经有1人回复
- 【求助】请高手帮忙查找用（-）DIP-Cl还原羰基的最早专利【有效期至2011-1-11】
已经有4人回复
- 大虾们帮帮忙，翻译一段日文专利啊，散尽金币啊！
已经有2人回复
- 【求助】帮忙推荐几本经典的光散射（或衍射）的书
已经有3人回复
4楼2011-12-23 16:05:56
2楼2011-12-23 15:55:09
3楼2011-12-23 16:04:49
【答案】应助回帖
★ ★
豆哥(金币+2): 感谢参与交流 2011-12-24 09:24:38
豆哥(金币+2): 感谢参与交流 2011-12-24 09:24:38
|
Intrauterine system for retaining and releasing therapeutically effective dose of e.g. biologically active compound within uterus of human for treatment of e.g. menorraghia, has retention elements retaining frame within uterus of mammal 专利号: US2010280464-A1 ; WO2010128004-A1 发明人: DE GRAAFF W, VEENSTRA H, MARTINE T M T, MULDERS T M T 专利权人和代码:ORGANON NV(ORGA-C) Derwent 主入藏号: 2010-N76468 [79] 被审查员引用的专利: 6 摘要: NOVELTY - The system (200) has a deposit i.e. rod-shaped deposit, of a therapeutically effective dose of a biologically active compound. A frame defines an interior space for receipt of the deposit, where the frame has an open structure allowing access to a part of an outer surface of the deposit. Multiple retention elements retain the frame within a uterus of a female mammal. The frame interacts with the deposit to form a mechanical structure having a bending stiffness greater than the sum of that of the frame and deposit taken individually. USE - Intrauterine system for retaining and releasing a therapeutically effective dose of a biologically active compound within uterus of female mammal i.e. human, for treatment of a medical condition e.g. dysfunctional uterine bleeding, menorraghia, dysmenorrhoea, endometriosis, uterine fibroids, climacteric complaints, osteoporosis and urogenital atrophy (all claimed). Uses include but are not limited to nomegestrol acetate (NOMAc), natural progesterone, levonogestrel, etonogestrel, dydrogesterone, medrogestone, medroxyprogesterone acetate, megestrol acetate, chlormadinone acetate and cyproterone acetate. ADVANTAGE - The part of the outer surface of the deposit is directly exposed to an environment due to the open structure of the frame, so that the rate controlling effect on a steady state release of the compound to the uterus can be primarily determined by the structure of the deposit and the environment in which the structure is placed, thus enabling relatively easy prediction of release rates within the frame. The flexible frame and the deposit interact to form a composite mechanical structure, so that the system has greater mechanical strength such as bending stiffness, thus achieving an improved structure that ensures adequate strength while ensuring ease of insertion due to the small cross-section of the frame. 详细说明 - INDEPENDENT CLAIMS are also included for the following: (1) a method for manufacturing an intrauterine system (2) a method for treating a female mammal. 附图说明 - The drawing shows a perspective view of an intrauterine system prior to assembly. Intrauterine system (200) Stem (204) Frame halves (205, 205') Living hinges (207, 207') Snap elements (209) 显示文献摘要 附图: 国际专利分类: A61M-037/00; B23P-011/00; A61F-006/00; A61F-006/14; A61K-009/00 德温特分类代码: A96 (Medical, dental, veterinary, cosmetic); B07 (General - tablets, dispensers, catheters); B01 (Steroids including systems with rings fused to basic steroid structure); P34 (Sterilising, syringes, electrotherapy); P56 (Machine tools) 德温特手工代码: A11-B07; A12-V03D; B01-C03; B01-C04; B01-C05; B11-C03; B11-C04; B12-M10; B12-M12L; B14-D01B; B14-D01C; B14-F08; B14-H05; B14-N01A; B14-N07; B14-N14; B14-S18 专利详细信息: 专利号 公开日期 主 IPC 周 页数 语种 US2010280464-A1 04 Nov 2010 A61M-037/00 201079 Pages: 11 English WO2010128004-A1 11 Nov 2010 A61F-006/14 201079 English 申请详细信息: US2010280464-A1 US770105 29 Apr 2010 WO2010128004-A1 WOEP055948 03 May 2010 优先权申请信息和日期: EP159353 04 May 2009 指定国家 (地区)/区域: WO2010128004-A1: 国家 (地区): AE; AG; AL; AM; AO; AT; AU; AZ; BA; BB; BG; BH; BR; BW; BY; BZ; CA; CH; CL; CN; CO; CR; CU; CZ; DE; DK; DM; DO; DZ; EC; EE; EG; ES; FI; GB; GD; GE; GH; GM; GT; HN; HR; HU; ID; IL; IN; IS; JP; KE; KG; KM; KN; KP; KR; KZ; LA; LC; LK; LR; LS; LT; LU; LY; MA; MD; ME; MG; MK; MN; MW; MX; MY; MZ; NA; NG; NI; NO; NZ; OM; PE; PG; PH; PL; PT; RO; RS; RU; SC; SD; SE; SG; SK; SL; SM; ST; SV; SY; TH; TJ; TM; TN; TR; TT; TZ; UA; UG; US; UZ; VC; VN; ZA; ZM; ZW 化合物 DCR 号 特征描述 DCR 号 特征描述 DCR 号 特征描述 102210-1-0-0 (K M) 6478-1-0-0 (K M) 94705-1-0-0 (K M) 13759-2-0-0 (K M) 100334-1-0-0 (K M) 100338-1-0-0 (K M) 100358-1-0-0 (K M) 90738-1-0-0 (K M) 166768-1-0-0 (K M) 102310-2-0-0 (K M) 环系索引号: 10975 Derwent 化合物号: 化合物号 特征描述 化合物号 特征描述 化合物号 特征描述 R19407 (K M) R00145 (K M) RA2UMU (K M) R15326 (K M) RA24UQ (K M) R00308 (K M) R12004 (K M) R01209 (K M) R01250 (K M) R04886 (K M) R13690 (K M) Derwent 注册号: 注册号 特征描述 注册号 特征描述 注册号 特征描述 0145 (S) 0308 (S) 1209 (S) 1250 (S) 这个是DII查到的信息，，wo专利里指定了CN的哦。 |
» 本帖已获得的红花（最新10朵）
xiangf5楼2011-12-23 16:07:28